Comparison of secular trends in cervical cancer mortality in China and the United States: An age-period-cohort analysis

International Journal of Environmental Research and Public Health

Volumn 13, Issue 11, 2016, Pages

  Wang, Jinyao ^a   Bai, Zhiqiang ^b   Wang, Zhenkun ^a   Yu, Chuanhua ^a  

^a WUHAN UNIVERSITY   (China)

^b HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Age period cohort analysis; Cervical cancer; Mortality

Indexed keywords

CANCER; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE TREATMENT; MORTALITY RISK;

ADULT; AGE; AGED; ARTICLE; CANCER MORTALITY; CHINA; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; RISK FACTOR; RURAL AREA; STANDARDIZATION; TREND STUDY; UNITED STATES; URBAN AREA; UTERINE CERVIX CANCER; COMPARATIVE STUDY; EPIDEMIOLOGY; FORECASTING; MIDDLE AGED; MORTALITY; SECOND CANCER; SOCIOECONOMICS; TRENDS; UTERINE CERVIX TUMOR; VERY ELDERLY; YOUNG ADULT;

CHINA; UNITED STATES;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHINA; COHORT STUDIES; FEMALE; FORECASTING; HUMANS; MIDDLE AGED; MORTALITY; NEOPLASMS, SECOND PRIMARY; SOCIOECONOMIC FACTORS; UNITED STATES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84996483266     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph13111148     Document Type: Article

References (35)

1. Hong,D.; Ye,F.; Chen,H.; Lu,W.; Cheng,Q.; Hu,Y.; Xie,X. Distribution of human papillomavirus genotypes in the patients with cervical carcinoma and its precursors in Zhejiang Province,China. Int. J. Gynecol. Cancer 2008,18,104–109.
2. Su,S.Y.; Huang,J.Y.; Ho,C.C.; Liaw,Y.P. Evidence for cervical cancer mortality with screening program in Taiwan,1981–2010: Age-period-cohort model. BMC Public Health 2013.
3. Vinh-Hung,V.; Bourgain,C.; Vlastos,G.; Cserni,G.; De Ridder,M.; Storme,G.; Vlastos,A.T. Prognostic value of histopathology and trends in cervical cancer: A SEER population study. BMC Cancer 2007.
4. Bellinger,J.D.; Brandt,H.M.; Hardin,J.W.; Bynum,S.A.; Sharpe,P.A.; Jackson,D. The role of family history of cancer on cervical cancer screening behavior in a population-based survey of women in the Southeastern United States. Womens Health Issues 2013,23,e197–e204.
5. Park,Y.; Vongdala,C.; Kim,J.; Ki,M. Changing trends in the incidence (1999–2011) and mortality (1983–2013) of cervical cancer in the Republic of Korea. Epidemiol. Health 2015,37,e2015024.
6. Leung,G.M.; Woo,P.P.; McGhee,S.M.; Cheung,A.N.; Fan,S.; Mang,O.; Thach,T.Q.; Ngan,H.Y. Age-period-cohort analysis of cervical cancer incidence in Hong Kong from 1972 to 2001 using maximum likelihood and Bayesian methods. J. Epidemiol. Community Health 2006,60,712–720.
7. Wang,T.; Wu,M.H.; Wu,Y.M.; Zhang,W.Y. A Population-based Study of Invasive Cervical Cancer Patients in Beijing: 1993–2008. Chin. Med. J. (Engl.) 2015,128,3298–3304.
8. Cain,J.M.; Ngan,H.; Garland,S.; Wright,T. Control of cervical cancer: Women’s options and rights. Int. J. Gynaecol. Obstet. 2009,106,141–143.
9. Yang,L.; Huangpu,X.; Zhang,S.; Lu,F.; Sun,X.; Sun,J.; Mu,R.; Li,L.; Qiao,Y. Changes of mortality rate for cervical cancer during 1970’s and 1990’s period in China. Acta Acad. Med. Sin. 2003,25,386–390.
10. Churilla,T.; Egleston,B.; Dong,Y.; Shaikh,T.; Murphy,C.; Mantia-Smaldone,G.; Chu,C.; Rubin,S.; Anderson,P. Disparities in the management and outcome of cervical cancer in the United States according to health insurance status. Gynecol. Oncol. 2016,141,516–523.
11. Saraiya,M.; Steben,M.; Watson,M.; Markowitz,L. Evolution of cervical cancer screening and prevention in United States and Canada: Implications for public health practitioners and clinicians. Prev. Med. 2013,57,426–433.
12. Taylor,R.J.; Morrell,S.L.; Mamoon,H.A.; Wain,G.V. Effects of screening on cervical cancer incidence and mortality in New South Wales implied by influences of period of diagnosis and birth cohort. J. Epidemiol. Community Health 2001,55,782–788.
13. Xie,S.H.; Chen,J.; Zhang,B.; Wang,F.; Li,S.S.; Xie,C.H.; Tse,L.A.; Cheng,J.Q. Time trends and age-period-cohort analyses on incidence rates of thyroid cancer in Shanghai and Hong Kong. BMC Cancer 2014.
14. Wang,P.D.; Lin,R.S. Age-period-cohort analysis of cervical cancer mortality in Taiwan,1974–1992. Acta Obstet. Gynecol. Scand. 1997,76,697–702.
15. Oh,C.M.; Jung,K.W.; Won,Y.J.; Shin,A.; Kong,H.J.; Lee,J.S. Age-Period-Cohort Analysis of Thyroid Cancer Incidence in Korea. Cancer Res. Treat. 2015,47,362–369.
16. Li,C. Temporal Trends of Chinese Female Breast Cancer Mortality Aged 20–84 Year Old: An Application of APC Model. Ph.D. Thesis,Wuhan University,Wuhan,China,2015.
17. Li,C.; Yu,C.; Wang,P. An age-period-cohort analysis of female breast cancer mortality from 1990–2009 in China. Int. J. Equity Health 2015.
18. Guo,P.; Li,K. Trends in esophageal cancer mortality in China during 1987–2009: Age,period and birth cohort analyzes. Cancer Epidemiol. 2012,36,99–105.
19. Wang,Z.; Bao,J.; Yu,C.; Wang,J.; Li,C. Secular Trends of Breast Cancer in China,South Korea,Japan and the United States: Application of the Age-Period-Cohort Analysis. Int. J. Environ. Res. Public Health 2015,12,15409–15418.
20. Woo,P.P.; Thach,T.Q.; Choy,S.T.; McGhee,S.M.; Leung,G.M. Modelling the impact of population-based cytologic screening on cervical cancer incidence and mortality in Hong Kong: An age-period-cohort approach. Br. J. Cancer 2005,93,1077–1083.
21. Segi,M. Cancer Mortality for Selected Sites in 24 Countries; Department of Public Health,Tohoku University of Medicine: Sendai,Japan,1960.
22. Doll,R.; Payne,P.; Waterhouse,J. Cancer Incidence in Five Continents; Union Internationale Contre le Cancer: Geneva,Switzerland,1966; Volume 1.
23. Wang,P.; Xu,C.; Yu,C. Age-period-cohort analysis on the cancer mortality in rural China: 1990–2010. Int. J. Equity Health 2014,13,1.
24. Yang,Y.; Schulhofer-Wohl,S.; Fu Wenjiang,J.; Land,K.C. The intrinsic estimator for age-period-cohort analysis: What it is and how to use it. Am. J. Sociol. 2008,113,1697–1736.
25. Yang,Y.; Fu,W.J.; Land,K.C. A methodological comparison of Age-Period-Cohort Models: The Intrinsic Estimator and Conventional Generalized Linear Models. Sociol. Methodol. 2004,34,75–110.
26. Park,J.; Jee,Y.H. Age-Period-Cohort Analysis of Liver Cancer Mortality in Korea. Asian Pac. J. Cancer Prev. 2015,16,8589–8594.
27. Zhang,H. Meta-Analysis of Risk Factors on Cervical Cancer among Women in China and America—The Important Role of HPV Virus Infection and Behavior Factors. Ph.D. Thesis,Huazhong University of Science and Technology,Wuhan,China,2010.
28. Vaccarella,S.; Lortet-Tieulent,J.; Plummer,M.; Franceschi,S.; Bray,F. Worldwide trends in cervical cancer incidence: Impact of screening against changes in disease risk factors. Eur. J. Cancer 2013,49,3262–3273.
29. Uchida,H.; Kobayashi,M.; Hosobuchi,A.; Ohta,A.; Ohtake,K.; Yamaki,T.; Uchida,M.; Odagiri,Y.; Natsume,H.; Kobayashi,J. Age,period,and birth cohort-specific effects on cervical cancer mortality rates in Japanese women and projections for mortality rates over 20-year period (2012–2031). Nihon Eiseigaku Zasshi 2014,69,215–224.
30. Tarone,R.E.; Chu,K.C. Age-period-cohort analyses of breast-,ovarian-,endometrial- and cervical-cancer mortality rates for Caucasian women in the USA. J. Epidemiol. Biostat. 2000,5,221–231.
31. Simard,E.P.; Naishadham,D.; Saslow,D.; Jemal,A. Age-specific trends in black-white disparities in cervical cancer incidence in the United States: 1975–2009. Gynecol. Oncol. 2012,127,611–615.
32. Ward,K.K.; Shah,N.R.; Saenz,C.C.; McHale,M.T.; Alvarez,E.A.; Plaxe,S.C. Changing demographics of cervical cancer in the United States (1973–2008). Gynecol. Oncol. 2012,126,330–333.
33. Benard,V.B.; Coughlin,S.S.; Thompson,T.; Richardson,L.C. Cervical cancer incidence in the United States by area of residence,1998 2001. Obstet. Gynecol. 2007,110,681–686.
34. Zhao,F.; Hu,S.; Zhang,S.; Chen,W.; Qiao,Y. Cervical cancer mortality in 2004–2005 and changes during last 30 years in China. Chin. J. Prev. Med. 2010,44,408–412.
35. Ito,Y.; Ioka,A.; Nakayama,T.; Tsukuma,H.; Nakamura,T. Comparison of trends in cancer incidence and mortality in Osaka,Japan,using an age-period-cohort model. Asian Pac. J. Cancer Prev. 2011,12,879–888.